Medical Marijuana, Inc.
MJNA · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.01 | 0.00 | -0.16 | 0.00 |
| FCF Yield | 2.60% | 7.75% | 8.35% | -0.71% |
| EV / EBITDA | 8.21 | -10.13 | 19.72 | -25.52 |
| Quality | ||||
| ROIC | 0.36% | -0.12% | 0.06% | 0.44% |
| Gross Margin | 77.89% | 73.28% | 78.80% | 80.55% |
| Cash Conversion Ratio | 0.13 | -0.34 | 5.39 | 0.12 |
| Growth | ||||
| Revenue 3-Year CAGR | -13.92% | -15.94% | -18.23% | -20.56% |
| Free Cash Flow Growth | -63.27% | -70.65% | 1,006.13% | -117.28% |
| Safety | ||||
| Net Debt / EBITDA | 3.85 | -4.78 | 4.67 | -4.97 |
| Interest Coverage | 7.91 | 2.67 | 0.15 | 11.37 |
| Efficiency | ||||
| Inventory Turnover | 0.44 | 0.72 | 0.45 | 0.39 |
| Cash Conversion Cycle | -121.57 | -86.44 | -39.41 | -19.70 |